Kidney transplant from HCV viremic donors to HCV-negative recipients and risk for de novo donor specific antibodies and acute rejection.

Background: Kidney transplantation from HCV-viremic donors into uninfected recipients is associated with excellent short-term outcomes. However, concerns regarding an increased risk for the development of de novo donor specific antibodies (DSA) and acute rejection have been raised in single center reports.

Methods: A retrospective study of HCV-negative kidney-only transplant recipients between 2018 and 2020.

Kidney transplant from hepatitis C viremic donors into aviremic recipients and risk for post-transplant BK and cytomegalovirus infection.

Background: kidney transplantation from Hepatitis C virus (HCV) viremic donors to uninfected recipients is associated with excellent short-term outcomes. However, HCV viremia might be associated with an increased risk for post-transplant viral complications.

Methods: We designed a retrospective study of HCV-negative kidney-only transplant recipients between 2018 and 2020.

Largest Experience of Safety and Efficacy of Patiromer in Solid Organ Transplant.

Supplemental Digital Content is available in the text.